Eastern Equine Encephalitis Antibody, IgM by IFA, Serum
ROMA Score for Ovarian Cancer Risk Assessment
Varicella Zoster Virus (VZV) Antibody, IgG and IgM
Biotinidase, Serum
Mycoplasma hominis, Molecular
Microsporidia species, Molecular Detection, PCR
Heroin, Urine
Biopsy, Pericardial
Saccharomyces cerevisiae Antibody, IgG
Human Immunodeficiency Virus (HIV) Drug Resistance (GenoSure), NGS
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Reference Ranges
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now
Loading...